JOURNEY MEDICAL CORPORATION - COMMON STOCK

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

07 май 2025 16:01:25 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: JOURNEY MEDICAL CORPORATION - COMMON STOCK

23 апр 2025 09:45:10 Источник NetDania Notify

NetDania - New 12 months High: JOURNEY MEDICAL CORPORATION - COMMON STOCK

22 апр 2025 16:02:52 Источник NetDania Notify

NetDania - New 12 months High: JOURNEY MEDICAL CORPORATION - COMMON STOCK

04 апр 2025 09:45:28 Источник NetDania Notify

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

01 апр 2025 16:01:16 Источник Nasdaq GlobeNewswire

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

26 мар 2025 16:01:00 Источник Nasdaq GlobeNewswire

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

24 мар 2025 08:30:00 Источник Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

19 мар 2025 16:01:56 Источник Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

12 мар 2025 08:30:49 Источник Nasdaq GlobeNewswire

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

05 мар 2025 16:01:06 Источник Nasdaq GlobeNewswire

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida

04 мар 2025 16:01:50 Источник Nasdaq GlobeNewswire

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

23 янв 2025 08:30:42 Источник Nasdaq GlobeNewswire

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

12 ноя 2024 16:01:12 Источник Nasdaq GlobeNewswire

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

04 ноя 2024 07:00:53 Источник Nasdaq GlobeNewswire

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

25 окт 2024 08:30:35 Источник Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

03 окт 2024 08:30:23 Источник Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

09 сен 2024 08:30:35 Источник Nasdaq GlobeNewswire

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

04 сен 2024 08:15:03 Источник Nasdaq GlobeNewswire

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

12 авг 2024 16:01:35 Источник Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

06 авг 2024 16:01:38 Источник Nasdaq GlobeNewswire